Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Corrigendum to “Upregulated Long Non-Coding Rnas Tmpo-As1, Ddx11-As1, and Pole Gene Expression Predict Poor Prognosis in Head and Neck Squamous Cell Carcinoma (Hnscc)” [Gene Rep. Volume 36, September 2024/101942] (Gene Reports (2024) 36, (S2452014424000657), (10.1016/J.Genrep.2024.101942))
Reza Shirkoohi
Reza Shirkoohi

Professor of Medical Genetics

Cancer Research Center

Tehran University of Medical Sciences

All Documents
1. Diagnostic Power of Micrornas in Melanoma: Integrating Machine Learning for Enhanced Accuracy and Pathway Analysis, Journal of Cellular and Molecular Medicine (2025)
2. Plskb: An Interactive Knowledge Base to Support Diagnosis, Treatment, and Screening of Lynch Syndrome on the Basis of Precision Oncology, JCO Clinical Cancer Informatics (2025)
3. Scientists Collaboration for Science Development and Peace: Usern View, Acta Medica Iranica (2025)
4. The Linc01270/Mir-29C-3P/Lox Axis Drives Gastric Cancer Progression: Bioinformatics and Experimental Validation, Biochemistry and Biophysics Reports (2025)
5. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
6. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
7. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
8. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
9. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
10. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
11. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
12. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
13. Haplotype Diversity of 17 Y-Str in the Iranian Population, BMC Genomics (2024)
14. Investigating the Role of Circulating Tumor Cells in Gastric Cancer: A Comprehensive Systematic Review and Meta-Analysis, Clinical and Experimental Medicine (2024)
15. Prediction of Novel Biomarkers for Gastric Intestinal Metaplasia and Gastric Adenocarcinoma Using Bioinformatics Analysis, Heliyon (2024)
16. Prevalence of Braf V600e and Nras (G12v, G13v) Mutations in Iranian Patients With Melanoma and Their Association With Tumor-Related Factors, Iranian Journal of Dermatology (2024)
17. Refining Breast Cancer Biomarker Discovery and Drug Targeting Through an Advanced Data-Driven Approach, BMC Bioinformatics (2024)
18. The Association Between the Glutathione S-Transferase Polymorphisms and Addiction to Opioids and Methamphetamine in the Iranian Population, Frontiers in Psychiatry (2024)
19. The Expression Analysis of Mest1 and Gja1 Genes in Gastric Cancer in Association With Clinicopathological Characteristics, International Journal of Hematology-Oncology and Stem Cell Research (2024)
20. A Study of Platelet-Derived Growth Factor a and Its Ligand Among Patients With Glioblastoma and Astrocytoma in Imam Khomeini Hospital Complex, Tehran, Journal of Advances in Medical and Biomedical Research (2023)
21. Activation of the Dna Damage Response Pathway in the Infected Gastric Tissue With Helicobacter Pylori: A Case-Control Study, Journal of Infection in Developing Countries (2023)
22. Allogeneic Mitochondrial Transplantation Ameliorates Cardiac Dysfunction Due to Doxorubicin: An in Vivo Study, Biomedicine and Pharmacotherapy (2023)
23. Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Frontiers in Oncology (2023)
24. Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Frontiers in Oncology (2023)
25. Evaluation of Igf2, Krt14, and Krt20 As Urinary Biomarkers in Patients With Bladder Cancer, Reports of Biochemistry and Molecular Biology (2023)
26. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
27. Global, Regional, and National Incidence of Six Major Immune-Mediated Inflammatory Diseases: Findings From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
28. A Case Report of the Sustained and Rapid Response of Bevacizumab in a Tp53-Positive Breast Cancer and Liver Metastatic Patient Through Personalized Medicine, Frontiers in Oncology (2022)
29. Association Between the Expression Levels of Microrna-101, -103, and -29A With Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients, Journal of Oncology (2022)
30. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
31. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
32. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
33. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
34. Estimates, Trends, and Drivers of the Global Burden of Type 2 Diabetes Attributable to Pm2·5 Air Pollution, 1990–2019: An Analysis of Data From the Global Burden of Disease Study 2019, The Lancet Planetary Health (2022)
35. Evaluation of Cx3cr1 Gene Dna Methylation in Developmental Dysplasia of the Hip (Ddh), Journal of Orthopaedic Surgery and Research (2022)
36. Evaluation of the Indication of Brca1/2 Genetic Tests in Iranian Women and Acceptance Rate of Risk-Reducing Surgeries in Brca Mutation Carriers, Molecular Genetics and Genomic Medicine (2022)
37. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
38. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
39. Mitotherapy in Doxorubicin Induced Cardiotoxicity: A Promising Strategy to Reduce the Complications of Treatment, Life Sciences (2022)
40. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
41. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
42. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
43. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
44. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
45. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
46. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
47. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
48. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
49. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
50. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
51. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
52. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
53. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
54. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
55. Study on Early Onset Melanoma and Germ-Line Mutation in Cdkn2a Among Patients in Imam Khomeini Hospital Complex, Asian Pacific Journal of Cancer Prevention (2021)
56. The Expression, Morphology, and Clinical Characteristics of Fibroblast Growth Factor-10 in Breast Cancer, Asia Pacific Journal of Cancer Biology (2021)
57. The Iranian Study of Opium and Cancer (Iropican): Rationale, Design, and Initial Findings, Archives of Iranian Medicine (2021)
58. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
59. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
60. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
61. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
62. Differential Expression of Scinderin and Gelsolin in Gastric Cancer and Comparison With Clinical and Morphological Characteristics, EXCLI Journal (2020)
63. Expression of Villin Associated With Epithelial to Mesenchymal Transition in Patients With Gastric Cancer Relating to Their Clinical and Morphological Specifications, Asia Pacific Journal of Cancer Biology (2020)
64. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
65. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
66. Gene Panel Testing in Hereditary Breast Cancer, Archives of Iranian Medicine (2020)
67. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
68. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
69. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
70. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
71. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
72. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
73. Human Cytomegalovirus Infection in Iranian Glioma Patients Correlates With Aging and Tumor Aggressiveness, Journal of Medical Virology (2020)
74. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
75. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
76. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
77. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
78. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
79. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
80. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
81. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
82. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
83. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
84. Prevalence and Attributable Health Burden of Chronic Respiratory Diseases, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Respiratory Medicine (2020)
85. Significance of E-Cadherin and Vimentin As Epithelial-Mesenchymal Transition Markers in Colorectal Carcinoma Prognosis, EXCLI Journal (2020)
86. The Global, Regional, and National Burden of Oesophageal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
87. Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: Axl, Gas6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer, Iranian Journal of Public Health (2019)
88. Dna Hypermethylation of Gdf5 in Developmental Dysplasia of the Hip (Ddh), Molecular Genetics and Genomic Medicine (2019)
89. Dysregulation of Mir-638 in Breast Cancer Patients and Bioinformatics Investigation of Its Target Genes in Apoptosis, Angiogenesis and Autophagy Pathways, International Journal of Cancer Management (2019)
90. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
91. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
92. Fibroblast Growth Factor-10 and Epithelialmesenchymal Transition in Colorectal Cancer, EXCLI Journal (2019)
93. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
94. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
95. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
96. Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980-2017, and Forecasts to 2030, for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, The Lancet HIV (2019)
97. Melatonin Ameliorates Tnbs-Induced Colitis in Rats Through the Melatonin Receptors: Involvement of Tlr4/Myd88/Nf-Κb Signalling Pathway, Inflammopharmacology (2019)
98. Plasma 5-Mirna As Biomarkers for Identifying Prostate Cancer Patients, Iranian Journal of Public Health (2019)
99. The Global Burden of Childhood and Adolescent Cancer in 2017: An Analysis of the Global Burden of Disease Study 2017, The Lancet Oncology (2019)
100. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
101. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
102. The Impact of Long-Term Exposure to Low Levels of Inorganic Arsenic on the Hypomethylation of Sept9 Promoter in Epithelial-Mesenchymal Transformed Colorectal Cancer Cell Lines, International Journal of Molecular and Cellular Medicine (2019)
103. The Nccn Criterion Young Age at Onset Alone Is Not an Indicator of Hereditary Breast Cancer in Iranian Population, Cancer Prevention Research (2019)
104. Correction To: Opium Consumption and the Incidence of Cancer: Does Opium Account As an Emerging Risk Factor for Gastrointestinal Cancer? (Journal of Gastrointestinal Cancer, 10.1007/S12029-017-0050-7), Journal of Gastrointestinal Cancer (2018)
105. Determination of E-Cadherin and Vimentin Genes Expression on the Tumor Specimens of Ovarian Cancer Patients, Tehran University Medical Journal (2018)
106. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
107. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
108. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
109. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
110. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
111. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
112. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
113. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
114. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
115. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
116. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
117. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
118. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
119. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
120. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
121. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
122. Mitochondrial Dna Copy Number Instability in Erbb2-Amplified Breast Cancer Tumors, EXCLI Journal (2018)
123. Opium Consumption and the Incidence of Cancer: Does Opium Account As an Emerging Risk Factor for Gastrointestinal Cancer?, Journal of Gastrointestinal Cancer (2018)
124. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
125. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
126. Precision in Oncology; a Future Prospect, Asian Pacific Journal of Cancer Prevention (2018)
127. A Patient With Desmoid Tumors and Familial Fap Having Frame Shift Mutation of the Apc Gene, Acta Medica Iranica (2017)
128. Antiretroviral Drug Resistance Mutations Among Hiv Treatment Failure Patients in Tehran, Iran, Iranian Journal of Public Health (2017)
129. Cyp17 Mspa1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran, Iranian Journal of Public Health (2017)
130. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
131. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
132. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
133. Measuring Progress and Projecting Attainment on the Basis of Past Trends of the Health-Related Sustainable Development Goals in 188 Countries: An Analysis From the Global Burden of Disease Study 2016, The Lancet (2017)
134. Prediction of Response to Irinotecan and Drug Toxicity Based on Pharmacogenomics Test: A Prospective Case Study in Advanced Colorectal Cancer, Asian Pacific Journal of Cancer Prevention (2017)
135. Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer, Iranian Journal of Public Health (2017)
136. The Association of Vimentin and Fibronectin Gene Expression With Epithelial-Mesenchymal Transition and Tumor Malignancy in Colorectal Carcinoma, EXCLI Journal (2017)
137. Atorvastatin Attenuates Tnbs-Induced Rat Colitis: The Involvement of the Tlr4/Nf-Kb Signaling Pathway, Inflammopharmacology (2016)
138. Birc5 Genomic Copy Number Variation in Early-Onset Breast Cancer, Iranian Biomedical Journal (2016)
139. Jak2v617f Allele Burden Measurement in Peripheral Blood of Iranian Patients With Myeloproliferative Neoplasms and Effect of Hydroxyurea on Jak2v617f Allele Burden, International Journal of Hematology-Oncology and Stem Cell Research (2016)
140. Melanoma in Iran: A Retrospective 10-Year Study, Asian Pacific Journal of Cancer Prevention (2016)
141. Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer, Iranian Journal of Public Health (2016)
142. Synthesis and Evaluation of a Glutamic Acid-Modified Hpamam Complex As a Promising Versatile Gene Carrier, Journal of Drug Targeting (2016)
143. Synthesis of a Novel Pegdga-Coated Hpamam Complex As an Efficient and Biocompatible Gene Delivery Vector: An in Vitro and in Vivo Study, Drug Delivery (2016)
144. Association Between Occludin Gene Expression and Clinical Morphological Characteristics in Breast Cancer, Tehran University Medical Journal (2015)
145. Cancer/Testis Oip5 and Taf7l Genes Are Up-Regulated in Breast Cancer, Asian Pacific Journal of Cancer Prevention (2015)
146. Expression Analysis of Microrna-125 in Patients With Polycythemia Vera and Essential Thrombocythemia and Correlation With Jak2 Allele Burden and Laboratory Findings, International Journal of Laboratory Hematology (2015)
147. Transcriptome Analysis of the Cancer/Testis Genes, Daz1, Aurkc, and Tex101, in Breast Tumors and Six Breast Cancer Cell Lines, Tumor Biology (2015)
148. Upregulation of Circulating Cancer Stem Cell Marker, Dclk1 But Not Lgr5, in Chemoradiotherapy-Treated Colorectal Cancer Patients, Tumor Biology (2015)
149. Concomitant Presence of Jak2 V617f Mutation and Bcr-Abl Translocation in a Pregnant Woman With Polycythemia Vera, Medical Oncology (2011)